Exicure Inc.
XCUR | NASDAQ
$1.22
-$0.04 (-3.17%)
Sep 22, 2026, 2:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -4.95M | -9.7M | -16.91M | -2.58M | -64.1M | -24.67M |
Depreciation & Amortization | 460K | 824K | 1.38M | 1.86M | 1.78M | 1.45M |
Stock-Based Compensation | 2K | 22K | 1.35M | 1.37M | 2.94M | 2.18M |
Other Working Capital | -377K | 1.33M | -356K | -33.76M | 22.51M | -18.72M |
Other Non-Cash Items | -4.58M | 5.31M | 2.92M | 514K | 460K | 99K |
Deferred Income Tax | -634K | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.14M | 631K | 914K | -36.82M | 24.11M | -18.33M |
Operating Cash Flow | -8.56M | -2.91M | -10.36M | -35.66M | -34.82M | -39.27M |
Capital Expenditures | -1K | n/a | n/a | -10K | -968K | -3.17M |
Cash Acquisitions | -1.81M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | -2M | -1.5M | -6.5M | -56.64M |
Sales Maturities Of Investments | n/a | n/a | n/a | 6M | 50.55M | 69.95M |
Other Investing Acitivies | n/a | n/a | 922K | 205K | n/a | n/a |
Investing Cash Flow | -1.81M | n/a | -1.08M | 4.7M | 43.09M | 10.14M |
Debt Repayment | n/a | 1M | n/a | -7.5M | -10M | 12.5M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | -1.77M | -645K | -362K | -344K |
Financial Cash Flow | 1.6M | 13.4M | 3.67M | -3.11M | 1.12M | 15.13M |
Net Cash Flow | -8.76M | 10.49M | -7.76M | -34.07M | 9.38M | -14M |
Free Cash Flow | -8.56M | -2.91M | -10.36M | -35.67M | -35.79M | -42.44M |
Adj. Free Cash Flow | -8.56M | -2.93M | -11.71M | -37.04M | -38.73M | -44.63M |
Maintenance CapEx | -1K | n/a | n/a | n/a | -968K | n/a |
Growth CapEx | n/a | n/a | n/a | -10K | n/a | -3.17M |
Owner Earnings | -8.56M | -2.91M | -10.36M | -35.66M | -35.79M | -39.27M |
Add to Watchlist
Select watchlists to add or remove XCUR